Answers are grounded in this paper and cite their sources.
Inflammatory bowel disease (IBD) is a chronic inflammatory condition affecting the gastrointestinal tract, primarily comprising Crohn’s disease (CD) and ulcerative colitis (UC). IBD can significantly impair patients’ health related quality of life (HRQoL). Although health-related quality of life in IBD has been widely studied in developed countries, evidence from sub-Saharan Africa, particularly Ethiopia, remains scarce. Therefore, this study aimed to assess HRQoL and its associated factors among patients with IBD in Ethiopia. A cross-sectional study was conducted from February 2022 to August 2022 among 84 patients with IBD who were receiving follow-up care at St. Paul Hospital Millennium Medical College. Data were collected from medical records and through patient interviews using the Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Descriptive statistics were presented as frequencies, medians, and means ± standard deviation (SD). Variables with a P-value < 0.20 in the bivariate analysis were included in the multivariable logistic regression analysis. A P-value < 0.05 was considered statistically significant. Of the 84 patients included in the final analysis, 69% were female. The mean age of the participants was 31.06 ± 10.7 years. Crohn’s disease and ulcerative colitis accounted for 62 (73.8%) and 22 (26.2%) patients, respectively. Impaired health-related quality of life (HRQoL) was observed in 68 patients (81%). Active disease (AOR: 9.8; 95% CI: 1.17-82; P = 0.03) and the presence of extra-intestinal manifestations (AOR:8.8; 95% CI:1.05-74; P = 0.04) were significantly associated with impaired HRQoL. The majority of patients with IBD in our Ethiopian study population had impaired health-related quality of life (HRQoL). Active disease and the presence of extraintestinal manifestations were significantly associated with impaired HRQoL. Because HRQoL extends beyond bowel symptoms, holistic care is particularly important for patients with active disease and extraintestinal manifestations.
No takes yet. Share an insight, caveat, or question.
Abie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: